Provided by Tiger Trade Technology Pte. Ltd.

Propanc Biopharma, Inc.

0.9495
-0.0405-4.09%
Volume:92.49K
Turnover:88.38K
Market Cap:3.33M
PE:-0.03
High:0.9762
Open:0.9734
Low:0.9371
Close:0.9900
52wk High:62.50
52wk Low:0.9150
Shares:3.50M
Float Shares:1.25M
Volume Ratio:0.37
T/O Rate:7.40%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-32.4560
EPS(LYR):-371.2241
ROE:-126.98%
ROA:-62.31%
PB:0.34
PE(LYR):0.00

Loading ...

Apr 08, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Apr 02, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Mar 31, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Mar 18, 2025

Major Issues Report

Form 8-K - Current report
Feb 14, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 12, 2025

Major Issues Report

Form 8-K - Current report
Dec 20, 2024

Major Issues Report

Form 8-K - Current report
Dec 06, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 30, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Sep 30, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Sep 27, 2024

Major Issues Report

Form 8-K - Current report
Aug 30, 2024

Major Issues Report

Form 8-K - Current report
Aug 15, 2024

Major Issues Report

Form 8-K - Current report
Aug 07, 2024

Major Issues Report

Form 8-K - Current report
Jul 02, 2024

Major Issues Report

Form 8-K - Current report
Jun 21, 2024

Major Issues Report

Form 8-K - Current report
Jun 13, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Jun 12, 2024

Major Issues Report

Form 8-K - Current report
Jun 05, 2024

Major Issues Report

Form 8-K - Current report